LeMaitre Vascular
LMAT
183 hedge funds and large institutions have $968M invested in LeMaitre Vascular in 2023 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 68 increasing their positions, 62 reducing their positions, and 15 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
27% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 15
15% more capital invested
Capital invested by funds: $845M → $968M (+$123M)
1.58% more ownership
Funds ownership: 83.5% → 85.08% (+1.6%)
1% more funds holding
Funds holding: 181 → 183 (+2)
10% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 62
94% less call options, than puts
Call options by funds: $5K | Put options by funds: $82K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Copeland Capital Management
Conshohocken,
Pennsylvania
|
+$4.24M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$2.21M |
| 3 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$2.01M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.79M |
| 5 |
Goldman Sachs
New York
|
+$1.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
-$10.1M |
| 2 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
-$4.25M |
| 3 |
BlackRock
New York
|
-$3.46M |
| 4 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
-$1.6M |
| 5 |
BG
Bahl & Gaynor
Cincinnati,
Ohio
|
-$1.45M |
LMAT Hedge Fund Activity: Q1 2023 in Review
183 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q1 2023, worth a combined $968M — up 15% from $845M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new LMAT positions and 15 closed out — a net gain of 4 holders — while 68 added to existing stakes and 62 trimmed.
The largest buyer was Copeland Capital Management, adding an estimated $4.24M. The largest seller was VOYA Investment Management, cutting an estimated $10.1M.
- 183 institutional investors held LeMaitre Vascular (LMAT) as of Q1 2023, up from 181 in Q4 2022.
- Funds reported $968M of LeMaitre Vascular stock for Q1 2023, up 15% quarter-over-quarter.
- 19 funds opened new LeMaitre Vascular positions in Q1 2023 and 15 closed out, a net change of +4 holders.
- The largest LeMaitre Vascular buyer in Q1 2023 was Copeland Capital Management, an estimated $4.24M added.
- The largest LeMaitre Vascular seller in Q1 2023 was VOYA Investment Management, an estimated $10.1M sold.
Based on aggregated 13F filings for Q1 2023.